HKD 2.95
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 3.37 Billion HKD | 5.13% |
2022 | 3.2 Billion HKD | 3.27% |
2021 | 3.1 Billion HKD | 27.61% |
2020 | 2.43 Billion HKD | 43.33% |
2019 | 1.69 Billion HKD | 13.69% |
2018 | 1.49 Billion HKD | -14.54% |
2017 | 1.74 Billion HKD | 11.53% |
2016 | 1.56 Billion HKD | -13.53% |
2015 | 1.81 Billion HKD | 107.94% |
2014 | 871.92 Million HKD | -26.59% |
2013 | 1.18 Billion HKD | 43.37% |
2012 | 828.5 Million HKD | 98.87% |
2011 | 416.61 Million HKD | -3.82% |
2010 | 433.14 Million HKD | 403.66% |
2009 | 86 Million HKD | -88.36% |
2008 | 738.77 Million HKD | 39.72% |
2007 | 528.76 Million HKD | 138.73% |
2006 | 221.49 Million HKD | 78.02% |
2005 | 124.41 Million HKD | -12.99% |
2004 | 142.99 Million HKD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 3.6 Billion HKD | 0.0% |
2023 FY | 3.37 Billion HKD | 5.13% |
2023 Q4 | 3.37 Billion HKD | 0.0% |
2023 Q2 | 3.38 Billion HKD | 0.0% |
2022 Q4 | 3.2 Billion HKD | 0.0% |
2022 FY | 3.2 Billion HKD | 3.27% |
2022 Q2 | 3.32 Billion HKD | 0.0% |
2021 FY | 3.1 Billion HKD | 27.61% |
2021 Q4 | 3.1 Billion HKD | 0.0% |
2021 Q2 | 2.47 Billion HKD | 0.0% |
2020 Q2 | 2.16 Billion HKD | 0.0% |
2020 FY | 2.43 Billion HKD | 43.33% |
2020 Q4 | 2.43 Billion HKD | 0.0% |
2019 Q2 | 1.57 Billion HKD | 0.0% |
2019 Q4 | 1.69 Billion HKD | 0.0% |
2019 FY | 1.69 Billion HKD | 13.69% |
2018 Q4 | 1.49 Billion HKD | 0.0% |
2018 FY | 1.49 Billion HKD | -14.54% |
2018 Q2 | 1.04 Billion HKD | 0.0% |
2017 Q4 | 1.74 Billion HKD | 0.0% |
2017 FY | 1.74 Billion HKD | 11.53% |
2017 Q2 | 1.64 Billion HKD | 0.0% |
2016 Q4 | 1.56 Billion HKD | 0.0% |
2016 FY | 1.56 Billion HKD | -13.53% |
2016 Q2 | 1.77 Billion HKD | 0.0% |
2015 FY | 1.81 Billion HKD | 107.94% |
2015 Q4 | 1.81 Billion HKD | 0.0% |
2015 Q2 | 1.21 Billion HKD | 0.0% |
2014 Q2 | 1.43 Billion HKD | 0.0% |
2014 Q4 | 871.92 Million HKD | 0.0% |
2014 FY | 871.92 Million HKD | -26.59% |
2013 Q4 | 1.18 Billion HKD | 0.0% |
2013 Q2 | 980.26 Million HKD | 0.0% |
2013 FY | 1.18 Billion HKD | 43.37% |
2012 FY | 828.5 Million HKD | 98.87% |
2012 Q2 | 565.23 Million HKD | 0.0% |
2012 Q4 | 828.5 Million HKD | 0.0% |
2011 Q4 | 416.61 Million HKD | 0.0% |
2011 FY | 416.61 Million HKD | -3.82% |
2011 Q2 | 376.45 Million HKD | 0.0% |
2010 Q4 | 433.14 Million HKD | 0.0% |
2010 Q2 | 522.65 Million HKD | 0.0% |
2010 FY | 433.14 Million HKD | 403.66% |
2009 Q4 | 86 Million HKD | 0.0% |
2009 FY | 86 Million HKD | -88.36% |
2008 FY | 738.77 Million HKD | 39.72% |
2007 FY | 528.76 Million HKD | 138.73% |
2006 FY | 221.49 Million HKD | 78.02% |
2005 FY | 124.41 Million HKD | -12.99% |
2004 FY | 142.99 Million HKD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pak Fah Yeow International Limited | 6.8 Million HKD | -49446.087% |
Grand Pharmaceutical Group Limited | 3.4 Billion HKD | 0.886% |
Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -2702.166% |
Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -631.987% |
Qianhai Health Holdings Limited | 487 Thousand HKD | -692731.211% |
Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -1552.83% |
Essex Bio-Technology Limited | 294.02 Million HKD | -1047.562% |
Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -910.742% |
PuraPharm Corporation Limited | 424.77 Million HKD | -694.333% |
JBM (Healthcare) Limited | 133.4 Million HKD | -2429.169% |
Jacobson Pharma Corporation Limited | 749.37 Million HKD | -350.251% |
China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 96.07% |